What is AC Immune Ltd?
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. The company's SupraAntigen and Morphomer platforms are designed to generate biologics and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 193.88M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.